Tur, C. http://orcid.org/0000-0003-1849-3184
Eshaghi, A.
Altmann, D. R.
Jenkins, T. M.
Prados, F. http://orcid.org/0000-0002-7872-0142
Grussu, F.
Charalambous, T.
Schmidt, A.
Ourselin, S.
Clayden, J. D.
Wheeler-Kingshott, C. A. M. G.
Thompson, A. J.
Ciccarelli, O.
Toosy, A. T.
Article History
Received: 25 January 2018
Accepted: 2 July 2018
First Online: 16 July 2018
Competing Interests
: C.T. has received an ECTRIMS Post-doctoral Research Fellowship in 2015. She has also received honoraria and support from travelling from Merck Serono, Sanofi, Roche, TEVA Pharmaceuticals, Novartis, Biogen, Bayer, Ismar Healthcare. A.E. has received a McDonald Fellowship from Multiple Sclerosis International Federation. A.E. has also received an ECTRIMS-MAGNIMS fellowship. F.P. is supported by a Guarantors of Brain non-clinical postdoctoral fellowship. FP has also received honoraria from Bioclinica Inc. F.G. is funded by the Horizon2020-EU.3.1 CDS-QUAMRI project (ref: 634541) and by the EPSRC Platform Grant for medical image computing for next-generation healthcare technology (ref: EP/M020533/1). S.O. is funded by the National Institute for Health Research University College London Hospitals Biomedical Research Centre (NIHR BRC UCLH/UCL High Impact Initiative BW.mn.BRC10269). S.O. also receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the MRC (MR/J01107X/1) and the NIHR Biomedical Research Unit (Dementia) at UCL. C.A.M.G.W.K. has received research grants (PI and co-applicant) from Spinal Research, Craig H. Neilsen Foundation, EPSRC, Wings for Life, UK MS Society, Horizon2020, NIHR/MRC. A.J.T. receives grant support from the Multiple Sclerosis Society of Great Britain and Northern Ireland. A.J.T. has also received honoraria/support for travel for consultancy from Eisai, Biogen (Optum Insight), and Excemed. He received support for travel from the International Progressive MS Alliance, as chair of their Scientific Steering Committee and the National MS Society (USA) as member of their Research Programs Advisory Committee, and receives an honorarium from SAGE Publishers as Editor-in-Chief of Multiple Sclerosis Journal. O.C. receives research grant support from the Multiple Sclerosis Society of Great Britain and Northern Ireland and the NIHR UCLH Biomedical Research Centre. O.C. is also a consultant for Teva, Roche, Novartis, Biogen, Genzyme and GE. She is an Associate Editor for Neurology, for which she receives an honorarium. A.T.T. has received speaker honoraria from Biomedia, Serono Symposia International Foundation, Bayer and meeting expenses from Biogen Idec. He is the local principal investigator for clinical trials in multiple sclerosis funded by MEDDAY Pharmaceuticals. D.R.A., T.M.J., F.G., T.C., A.S. and J.D.C. declare no competing interests.